NANOPARTICLE CARRIERS FOR DRUG ADMINISTRATION AND PROCESS FOR PRODUCING SAME

(19)

(11)

EP 2 249 817 B8

(12)	CORRECTED EUROPEAN PATENT SPECIFICATION
	Note: Bibliography reflects the latest situation

(15)	Correction information:
	Corrected version no 1 (W1 B1)

(48)	Corrigendum issued on:
	21.03.2012 Bulletin 2012/12

(45)	Mention of the grant of the patent:
	21.12.2011 Bulletin 2011/51

(21)	Application number: 08733215.1

(22)	Date of filing: 18.02.2008

(51)

International Patent Classification (IPC):

A61K 9/51^(2006.01)

(86)	International application number:
	PCT/ZA2008/000012

(87)	International publication number:
	WO 2009/105792 (27.08.2009 Gazette 2009/35)

(54)	NANOPARTICLE CARRIERS FOR DRUG ADMINISTRATION AND PROCESS FOR PRODUCING SAME NANOTEILCHEN-TRÄGER ZUR VERABREICHUNG VON ARZNEIMITTELN UND VERFAHREN ZU IHRER HERSTELLUNG VECTEURS DE NANOPARTICULES POUR L ADMINISTRATION DE MÉDICAMENTS ET PROCÉDÉ POUR LEUR PRODUCTION

(84)	Designated Contracting States:
	AT BE BG CH CY CZ DE DK EE ES FI FR GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR

(43)	Date of publication of application:
	17.11.2010 Bulletin 2010/46

(73)	Proprietor: CSIR
	Pretoria 0040 (ZA)

(72)	Inventor:
	KALOMBO, Lonji 0083 Pretoria (ZA)

(74)	Representative: Håmsø Patentbyrå ANS
	Postboks 171 4302 Sandnes 4302 Sandnes (NO)

(56)

References cited: :

EP-A- 1 595 549

WO-A-03/099262

Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).